NEUMORA THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.9 USD | +2.17% |
|
+7.96% | -41.94% |
Chart calendar Neumora Therapeutics, Inc.
e5d996deff597b.7QKiMD3QDz6BLbeW230EbGGQ51TiwEjKndHoCGV_jl8.gXvIQA2GV3nxT-jkjw01PwLJgSeq8X2d0pmZbw1Lvj7aVuV8ReV5DeNMhw~c30310e53ab00b88a37b41dc1498b254
Past events on Neumora Therapeutics, Inc.
| 2024-05-15 09:00 am | RBC Capital Markets Global Healthcare Conference |
| 2024-05-14 01:00 pm | BofA Securities Health Care Conference |
| 2024-05-07 07:00 am | Q1 2024 Earnings Release |
| 2024-03-20 11:00 am | Stifel Virtual CNS Conference - Fireside Chat |
| 2024-03-07 07:00 am | Q4 2023 Earnings Release |
| 2024-01-08 02:15 pm | JPMorgan Healthcare Conference |
| 2023-11-15 11:30 am | Stifel Healthcare Conference - Fireside Chat |
| 2023-11-06 01:50 pm | Guggenheim Securities Inflammation & Immunology Conference - Fireside Chat |
| 2023-11-01 07:00 am | Q3 2023 Earnings Release |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 |
|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | -251 -188 -33.9% | -245 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -252 -195 -29.44% | -253 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -236 -184 -27.77% | -244 |
|
Net income Million USD | Released Forecast Spread | -131 | -236 -181 -30.29% | -237 |
|
EPS USD | Released Forecast Spread | -0,61 | -3,63 -1,85 -95.85% | -1,48 |
| Announcement Date | 02/05/23 | 07/03/24 | - |
Quarterly results
| Fiscal Period | December | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 |
|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | -56,7 -56,0 -1.23% | -114 -58,9 -93.27% | -54,0 | -62,0 | ||||
|
EBIT Million USD | Released Forecast Spread | -56,9 -49,3 -15.28% | -114 -60,8 -87.55% | -60,1 -55,9 -7.54% | -62,3 | -65,4 | -67,9 | ||
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -53,0 -49,5 -7.2% | -108 -57,3 -89.36% | -53,7 -55,0 2.27% | -60,7 | -64,0 | -65,9 | ||
|
Net income Million USD | Released Forecast Spread | -53,0 -49,5 -7.2% | -109 -57,3 -89.83% | -53,7 -55,0 2.27% | -60,7 | -64,0 | -65,9 | ||
|
EPS USD | Released Forecast Spread | -0,40 | -0,71 -0,58 -21.49% | -0,34 -0,35 1.82% | -0,37 | -0,39 | -0,39 | -0,38 | -0,39 |
| Announcement Date | 01/11/23 | 07/03/24 | 07/05/24 | - | - | - | - | - |
| 2024-07-15 01:45 am | ADDLIFE AB: Q2 2024 Earnings Release |
| 2024-07-21 | MEDPACE HOLDINGS, INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | SYNGENE INTERNATIONAL LIMITED: Q1 2025 Earnings Release (Projected) |
| 2024-07-23 | ALKERMES PLC: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | IQVIA HOLDINGS INC.: Q2 2024 Earnings Release (Projected) |
| 2024-07-23 | ICON PUBLIC LIMITED COMPANY: Q2 2024 Earnings Release (Projected) |
| 2024-07-24 | LONZA GROUP AG: Q2 2024 Earnings Release |
| 2024-07-25 01:00 am | BACHEM HOLDING AG: Q2 2024 Earnings Release |
| 2024-07-25 | PHARVARIS N.V.: Q2 2024 Earnings Release (Projected) |
| 2024-07-26 01:00 am | BB BIOTECH AG: Q2 2024 Earnings Release |
Past sector events for Neumora Therapeutics, Inc.
| 2024-05-29 04:01 pm | IMMUNOVANT, INC.: Q4 2024 Earnings Release |
| 2024-05-23 07:00 am | CUREVAC N.V.: Q1 2024 Earnings Release |
| 2024-05-22 01:00 am | EVOTEC SE: Q1 2024 Earnings Release |
| 2024-05-21 05:14 pm | ALVOTECH: Q1 2024 Earnings Release |
| 2024-05-21 07:00 am | EXSCIENTIA PLC: Q1 2024 Earnings Release |
| 2024-05-17 02:00 am | BIOARCTIC AB: Q1 2024 Earnings Release |
| 2024-05-15 04:05 pm | CULLINAN THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-15 07:00 am | PERSPECTIVE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 2024-05-14 | GNI GROUP LTD.: Q1 2024 Earnings Release |
| 2024-05-14 04:05 pm | KYVERNA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- NMRA Stock
- Calendar Neumora Therapeutics, Inc.
